Grand Rounds February 23, 2024: Virtual Vigilance: Monitoring of Decentralized Clinical Trials (Adrian Hernandez, MD; Christopher J. Lindsell, PhD)
Rethinking Clinical Trials
FEBRUARY 28, 2024
Under RBM, the process by which study materials get to participants should be considered high risk and monitored accordingly. Outcomes including patient reported outcomes, functional assessments including via digital technology, healthcare events or mortality may require identify verification. I think we must.
Let's personalize your content